Nachrichten zur Biodelivery Sciences International Inc. Aktie

BioDelivery Sciences to Report Third Quarter 2020 Financial Results on November 5, 2020

RALEIGH, N.C., Oct. 23, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty…

BioDelivery Sciences International, Inc. (BDSI) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biodelivery Sciences International Inc (BDSI) Q2 2020 Earnings Call Transcript

BDSI earnings call for the period ending June 30, 2020....…

BIODELIVERY SCIENCES INTERNATIONAL INC: 10-Q Report

10-Q...…

BioDelivery Sciences International, Inc. (BDSI) Management on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International, Inc. 2020 Q2 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International (BDSI) Q2 Earnings Lag Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of -75.00% and 0.87%, respectively, for the quarter ended June 2020. Do the…

BioDelivery Sciences EPS misses by $0.02, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences Reports Strong Q2 2020 Results

Second Quarter Total Company Net Revenue Increased 23% versus Prior Year to $36.6 Million...…

BioDelivery Sciences to Report Second Quarter 2020 Financial Results on August 5, 2020

RALEIGH, N.C., July 27, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty…

BioDelivery Sciences: Fundamentals Continue Divergence From Share Price

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences (BDSI) Presents At Jefferies Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences to Present at Two Upcoming Investor Conferences

RALEIGH, N.C., May 29, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical…

BioDelivery Sciences Appoints Jeff Bailey Interim CEO

RALEIGH, N.C., May 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc (NASDAQ: BDSI), a rapidly growing specialty…

BioDelivery Sciences: Undervalued $5 Biopharma Still Growing Despite COVID-19

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery (BDSI) Beats on Q1 Earnings, Withdraws Guidance

BioDeliverys (BDSI) strong Belubca sales drive the topline. Symproic further boosts revenues. Stock up....…

BioDelivery Sciences International, Inc. (BDSI) CEO Herm Cukier on Q1 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences International (BDSI) Beats Q1 Earnings and Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 400.00% and 15.33%, respectively, for the quarter ended March 2020. Do the…

BioDelivery Sciences International, Inc. 2020 Q1 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences EPS beats by $0.03, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020

RALEIGH, N.C., April 28, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty…

BioDelivery Sciences Strong As Ever But At Half The Price

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bully For BioDelivery Sciences

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery (BDSI) Q4 Earnings and Revenues Beat Estimates

BioDelivery (BDSI) beats earnings and sales expectations for the fourth quarter of 2019....…

Biodelivery Sciences International Inc (BDSI) Q4 2019 Earnings Call Transcript

BDSI earnings call for the period ending December 31, 2019....…

BioDelivery Sciences International (BDSI) Tops Q4 Earnings and Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 700.00% and 4.98%, respectively, for the quarter ended December 2019. Do the…

BioDelivery Sciences International, Inc. (BDSI) CEO Herm Cukier on Q4 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of Directors

Mr. Bailey Further Strengthens Company Leadership Bringing more than 30 Years of Significant Industry Experience including Commercial Operations and Board…

BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy-

BioDelivery (BDSI) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicines 36th Annual Meeting

BELBUCA® Effect on Respiratory Drive was Comparable to Placebo in Clinical Trial at all Tested Doses...…

Heres Why You Should Add BioDelivery Stock to Your Portfolio

Here are five reasons which make BioDelivery (BDSI)) a good investment option in 2020....…

What Makes BioDelivery (BDSI) a New Buy Stock

BioDelivery (BDSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a…

BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development

RALEIGH, N.C., Jan. 06, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI), a rapidly growing specialty…

BioDelivery Sciences: Still Some Upside

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Are You Looking for a Top Momentum Pick- Why BioDelivery Sciences International (BDSI) is a Great Choice

Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Lets find…

BioDelivery Sciences Added to NASDAQ Biotechnology Index

RALEIGH, N.C., Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI), a rapidly growing commercial-stage…

BioDelivery Sciences stock price target raised to $9 from $8 at SunTrust RH

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioDelivery (BDSI) Up 6% Since Last Earnings Report: Can It Continue-

BioDelivery (BDSI) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now-

Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Lets find…

BioDeliverys Belbuca Sales & Symproic Addition Encouraging

BioDeliverys (BDSI) efforts to increase preferred coverage for Belbuca and the acquisition of the rights to Symproic are likely to…

BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference

RALEIGH, N.C., Nov. 27, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty…

BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors

Dr. Singh is renowned for her expertise in molecular science, clinical management and national health policy Dr. Singh is renowned…

The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical

The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical...…